Trastuzumab (Herceptin) is a monoclonal antibody directed against the HER2/neu receptor. It is used mainly in metastatic breast cancer although some patients with early disease are now also given trastuzumab.  
  
Adverse effects  
* flu\-like symptoms and diarrhoea are common
* cardiotoxicity
	+ more common when anthracyclines have also been used
	+ an echo is usually performed before starting treatment
